Menu
 

Search abstracts


Rapid advice guidelines for the pharmacological management of ha in patients with liver cirrhosis

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: LI, Huibo (peking univercity third hospital)
  • Co-author(s): Huibo Li
    Peng Men
    Yu Wang
    Wenxi Liu
    Xiaoyuan XU
    Jidong Jia
    Zhongping Duan
    Jie Xu
    Suodi Zhai
    Zhu Zhu
    Zhigang Zhao
    Yaolong Chen
  • Abstract:

    Background

    Human albumin (HA) is widely used in hepatology due to support from international scientific societies for the treatment or prevention of severe complications in cirrhosis. However, no formal guidelines exist regarding its use in China, and in many clinical situations, limited evidence is available due to its high cost and the use of..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses